Literature DB >> 26730747

Using Molecular Phenotyping to Guide Improvements in the Histologic Diagnosis of T Cell-Mediated Rejection.

J Reeve1, J Chang1, I D R Salazar1,2, M Merino Lopez1, P F Halloran1,3.   

Abstract

Recognition that some lesions typical of T cell-mediated rejection (TCMR) also occur in antibody-mediated rejection requires revision of the histologic TCMR definition. To guide this process, we assessed the relative importance of various lesions and the performance of new histology diagnostic algorithms, using molecular TCMR scores as histology-independent estimates of true TCMR. In 703 indication biopsies, random forest analysis and logistic regression indicated that interstitial infiltrate (i-lesions) and tubulitis (t-lesions) were the key histologic predictors of molecular TCMR, with arteritis (v-lesions) having less importance. Histology predicted molecular TCMR more accurately when diagnoses were assigned by strictly applying the Banff rules to the lesion scores and redefining isolated v-lesion TCMR. This improved prediction from area under the curve (AUC) 0.70 with existing rules to AUC 0.80. Further improvements were achieved by introducing more categories to reflect inflammation (AUC 0.84), by summing the lesion scores (AUC 0.85) and by logistic regression (AUC 0.90). We concluded that histologic assessment of TCMR can be improved by placing more emphasis on i- and t-lesions and incorporating new algorithms for diagnosis. Nevertheless, some discrepancies between histologic and molecular diagnoses persist, partially due to the inherent nonspecificity of i- and t-lesions, and molecular methods will be required to help resolve these cases. © Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  basic (laboratory) research / science; biopsy; clinical research / practice; kidney transplantation / nephrology; molecular biology; rejection: T cell mediated (TCMR)

Mesh:

Substances:

Year:  2016        PMID: 26730747     DOI: 10.1111/ajt.13572

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  9 in total

Review 1.  Enhancing the Value of Histopathological Assessment of Allograft Biopsy Monitoring.

Authors:  Michelle A Wood-Trageser; Andrew J Lesniak; Anthony J Demetris
Journal:  Transplantation       Date:  2019-07       Impact factor: 4.939

Review 2.  Current status of alloimmunity.

Authors:  Thiago J Borges; Naoka Murakami; Leonardo V Riella
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-11       Impact factor: 2.894

3.  B Cell Receptor Genes Associated With Tolerance Identify a Cohort of Immunosuppressed Patients With Improved Renal Allograft Graft Function.

Authors:  A Asare; S Kanaparthi; N Lim; D Phippard; F Vincenti; J Friedewald; M Pavlakis; E Poggio; P Heeger; R Mannon; B E Burrell; Y Morrison; N Bridges; I Sanz; A Chandraker; K A Newell; L A Turka
Journal:  Am J Transplant       Date:  2017-05-02       Impact factor: 8.086

Review 4.  Molecular assessment of disease states in kidney transplant biopsy samples.

Authors:  Philip F Halloran; Konrad S Famulski; Jeff Reeve
Journal:  Nat Rev Nephrol       Date:  2016-06-27       Impact factor: 28.314

Review 5.  Molecular Assessment of Kidney Allografts: Are We Closer to a Daily Routine?

Authors:  A Trailin; P Hruba; O Viklicky
Journal:  Physiol Res       Date:  2020-03-23       Impact factor: 1.881

6.  Acute Rejection Phenotypes in the Current Era of Immunosuppression: A Single-Center Analysis.

Authors:  Caroline Wehmeier; Patrizia Amico; Patricia Hirt-Minkowski; Argyrios Georgalis; Gideon Höenger; Thomas Menter; Michael Mihatsch; Felix Burkhalter; Juerg Steiger; Michael Dickenmann; Helmut Hopfer; Stefan Schaub
Journal:  Transplant Direct       Date:  2017-02-09

7.  Polyomavirus BK Nephropathy-Associated Transcriptomic Signatures: A Critical Reevaluation.

Authors:  Ling Pan; Zili Lyu; Benjamin Adam; Gang Zeng; Zijie Wang; Yuchen Huang; Zahidur Abedin; Parmjeet Randhawa
Journal:  Transplant Direct       Date:  2018-02-02

8.  Early isolated V-lesion may not truly represent rejection of the kidney allograft.

Authors:  Mariana Wohlfahrtova; Petra Hruba; Jiri Klema; Marek Novotny; Zdenek Krejcik; Viktor Stranecky; Eva Honsova; Petra Vichova; Ondrej Viklicky
Journal:  Clin Sci (Lond)       Date:  2018-10-29       Impact factor: 6.124

9.  Diagnostic Biomarkers and Immune Infiltration in Patients With T Cell-Mediated Rejection After Kidney Transplantation.

Authors:  Hai Zhou; Hongcheng Lu; Li Sun; Zijie Wang; Ming Zheng; Zhou Hang; Dongliang Zhang; Ruoyun Tan; Min Gu
Journal:  Front Immunol       Date:  2022-01-04       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.